Seeking Alpha

More on CVS Caremark's Q4

  • CVS Caremark (CVS) saw broad sales growth in Q4, with Pharmacy Services revenue up 5.2% and Retail Pharmacy sales growth of 5.6%.
  • Retail Pharmacy Segment same store sales rose 4.0% during the period.
  • Gross profit rate fell 60 bps to 30.7%.
  • The company expects 2014 EPS of $4.36-$4.50 vs. $4.47 consensus.
  • A conference call is scheduled for 8:30 am where more details on the company's exit from tobacco could be discussed. (webcast)
  • CVS +0.7% premarket
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|